About AMGIS Lifescience
AMGIS Lifescience is a Healthcare company based in Vapi (India) founded in 2016. It manufactures veterinary and human health APIs with global supply and quality assurance. It operates on a B2B and Export Manufacturing model. Its Indian entity Amgis Lifescience Limited reported revenue of ₹68.51 Cr. AMGIS Lifescience offers products and services including Albendazole, Salbutamol Sulphate, Diminazene Aceturate, Levosalbutamol Sulphate, and Fenbendazole. Its focus areas include Pharmaceuticals, API Manufacturing, Veterinary APIs and Human Health APIs. Its competitors include Viyash, Inventys and Blue Jet Healthcare; 2 of its 3 listed competitors have raised funding.
Company details
AMGIS Lifescience Ltd. produces Active Pharmaceutical Ingredients for veterinary and human health, operating advanced facilities in Gujarat, India, compliant with GMP and WHO standards. They manufacture products like Albendazole for animals and Salbutamol Sulphate for humans, focusing on quality control and periodic monitoring. The company exports to over 70 countries, serving international corporations and startups through B2B channels.
- Headquarters Vapi, India
- SectorsHealthcare
- Phone•••• ••••
- Website amgislifescience.com
- Social LinkedIn YouTube
- Legal Name Amgis Lifescience Limited
- Date of Incorporation 22 Sep, 1971
- Jurisdiction Vapi, Gujarat, India
- Annual Revenue₹68.51 Cr
FY 2024 · +13% YoY
- Net Profit₹3.13 Cr
FY 2024 · 5% margin
- EBITDA₹11.27 Cr
FY 2024 · 16% margin
Associated legal entities of AMGIS Lifescience
AMGIS Lifescience operates through Amgis Lifescience Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Amgis Lifescience Limited CIN U99999GJ1971PLC109282 | Active | 22 Sep 1971 | Vapi, Gujarat | ₹68.5 Cr | 4 | View details |
Products & Services of AMGIS Lifescience
AMGIS Lifescience offers a comprehensive portfolio of products and services, including Albendazole, Salbutamol Sulphate, Diminazene Aceturate, Levosalbutamol Sulphate, and Fenbendazole.
Anthelmintic for treating parasites in animals
Anti-asthmatic drug for respiratory conditions
Antiprotozoal for animal health issues
Medication for asthma and bronchitis
Anthelmintic to control worms in animals
Respiratory aid for clearing mucus
Benzimidazole anthelmintic for livestock
Treatment for cardiovascular diseases
Anti-inflammatory and pain relief drug
Apps and channels of AMGIS Lifescience
its YouTube channel AMGIS Lifescience Ltd. has 13 subscribers.
Board of directors of Amgis Lifescience Limited (AMGIS Lifescience)
Amgis Lifescience Limited is the primary company behind AMGIS Lifescience. The board of Amgis Lifescience Limited currently have 3 directors; the longest-serving is Shantaben Dharmendrabhai Patel, appointed in 2016. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shantaben Dharmendrabhai Patel DIN 02438326 | Director | 19 Aug 2016 | 10 yrs 2 mo | Amgis Lifescience Limited |
| Dharmendrabhai Mulchandbhai Patel DIN 00072434 | Director | 19 Aug 2016 | 10 yrs 2 mo | Amgis Lifescience Limited |
| Yash Dharmendrabhai Patel DIN 09425179 | Whole-time director | 06 Dec 2021 | 4 yrs 11 mo | Amgis Lifescience Limited |
Financials of AMGIS Lifescience
Figures of Amgis Lifescience Limited, the primary company behind AMGIS Lifescience, for FY 2024. Revenue was ₹68.51 Cr (+13% year on year). Net profit was ₹3.13 Cr (5% margin). EBITDA was ₹11.27 Cr (16% margin). Revenue has grown at a compounded annual rate of +6% over three years and +23% over five years.
- ₹68.51 CrRevenue · FY 2024 · +13% YoY
- ₹3.13 CrNet profit · 5% margin
- ₹11.27 CrEBITDA · 16% margin
- ₹4.50 CrPaid-up capital
- +6%Revenue CAGR, 3 years
- +23%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Amgis Lifescience Limited are on its company page.
Detailed financial statements for AMGIS Lifescience
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of AMGIS Lifescience
AMGIS Lifescience has 3 listed competitors in our database, 2 of them funded. They include Viyash, Inventys and Blue Jet Healthcare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viyash.com | 2019 | Hyderabad, India | $120.02M | 277 | APIs and intermediates are manufactured by Viyash as a CDMO. | |
| inventys.in | 2005 | Mumbai, India | $64.34M | 219 | Actives, advanced intermediates, and specialty chemicals are custom manufactured. | |
| bluejethealthcare.com | 1969 | Mumbai, India | 476 | CDMO focused on manufacturing, supplier, and development of intermediates & APIs |
Detailed competitors of AMGIS Lifescience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AMGIS Lifescience
The website of AMGIS Lifescience (amgislifescience.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 0.9% vs previous month
Websites whose visitors overlap most with AMGIS Lifescience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| rakshitdrugspvtltd.com | 36% | 1.6K | #10,060,097 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AMGIS Lifescience
AMGIS Lifescience was founded in 2016.
AMGIS Lifescience is headquartered in Vapi, India. It is registered at Vapi, Gujarat, India.
The primary company behind AMGIS Lifescience, Amgis Lifescience Limited, reported revenue of ₹68.51 Cr for FY 2024, up 13% year on year.
AMGIS Lifescience Ltd. produces Active Pharmaceutical Ingredients for veterinary and human health, operating advanced facilities in Gujarat, India, compliant with GMP and WHO standards. They manufacture products like Albendazole for animals and Salbutamol Sulphate for humans, focusing on quality control and periodic monitoring. The company exports to over 70 countries, serving international corporations and startups through B2B channels.
AMGIS Lifescience's top competitors include Inventys, Viyash and Blue Jet Healthcare.
AMGIS Lifescience offers Albendazole, Salbutamol Sulphate, Diminazene Aceturate, Levosalbutamol Sulphate, and 5 more products and services.
AMGIS Lifescience operates through Amgis Lifescience Limited.
The legal entities of AMGIS Lifescience currently have 4 directors, including Shantaben Dharmendrabhai Patel, Dharmendrabhai Mulchandbhai Patel, Yash Dharmendrabhai Patel and others.